MR imaging of the gastrointestinal tract with IV gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT

American Journal of Roentgenology

Volumn 169, Issue 4, 1997, Pages 1051-1059

  Low, Russell N ^a   Francis, Isaac R ^b  

^a SHARP HEALTHCARE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARIUM SULFATE; GADOLINIUM; GADOLINIUM PENTETATE MEGLUMINE; IODINATED CONTRAST MEDIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0030922872     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.169.4.9308464     Document Type: Article

References (31)

1. Brown JJ. Gastrointestinal contrast agents for MR imaging. Magn Reson Imaging Clin N Am 1996;4:25-35
2. Kettritz U, Shoenut JP, Semelka RC. MR imaging of the gastrointestinal tract. Magn Reson Imaging Clin N Am 1995;3:87-98
3. Gore RM, Balthazar EJ, Ghahremani GG, Miller FH. CT features of ulcerative colitis and Crohn's disease. AJR 1996;167:3-15
4. Maglinte DD, Gage SN, Harmon BH, et al. Obstruction of the small intestine: accuracy and role of CT in diagnosis. Radiology 1993;88:61-64
5. Zerhouni EA, Rutter C, Hamilton SR, et al. CT and MR imaging in the staging of colorectal carcinoma: report of the Radiology Diagnostic Oncology Group II. Radiology 1996;200:443-451
6. Brown JJ, Duncan JR, Heiken JP, et al. Perfluorcytlbromide as a gastrointestinal contrast agent for MR imaging: use with and without glucagon. Radiology 1991;181:455-460
7. Heusler RCH, Wright E, Marincek B. Oral superparamagnetic contrast agent (ferumoxsil): tolerance and efficacy in MR imaging of gynecologic disease. J Magn Reson Imaging 1995;5:385-391
8. Patten RM, Lo SK, Phillips JJ, et al. Positive bowel contrast agent for MR imaging of the abdomen: phase II and III clinical trials. Radiology 1993;189:277-283
9. Kaminsky S, Laniado M, Gogoll M, et al. Gadopentetate dimeglumine as a bowel contrast agent: safety and efficacy. Radiology 1991;178:503-508
10. Li KCP, Tart RP, Fitzsimmons JR, et al. Barium sulfate suspension as a negative oral MRI contrast agent: in vitro and human optimization studies. Magn Reson Imaging 1991;9:141-150
11. Mitchell DG, Vintiski S, Mohamed FB, Mammone FJ, Hadet K, Rifkin MD. Comparison of Kaopectate with barium for negative and positive enteric contrast at MR imaging. Radiology 1991;181:475-480
12. Ros PR, Steinman RM, Torres GM, et al. The value of barium as a gastrointestinal contrast agent in MR imaging: a comparison study in normal volunteers. AJR 1991;157:761-767
13. Anderson CM, Brown JJ, Balfe DM, et al. MR imaging of Crohn disease: use of perflubron as a gastrointestinal contrast agent. J Magn Reson Imaging 1994;4:491-496
14. Low RN, Carter WD, Saleh F, Sigeti JS. Ovarian cancer: comparison of findings with perfluorocarbon-enhanced MR imaging, In-111-CYT-103 immunoscintigraphy, and CT. Radiology 1995;195:391-400
15. Low RN, Sigeti JS. Double contrast MR imaging of the gastrointestinal tract with intravenous Gd-DTPA and perflubron oral contrast material (abstr). Radiology 1995;197(P):349
16. Matsushita M, Oi H, Murakami T, et al. Extraserosal invasion in advanced gastric cancer: evaluation with MR imaging. Radiology 1994;192:87-91
17. Chou CK, Chen LT, Sheu RS, Wang ML, Jaw TS, Liu GC. MRI manifestations of gastrointestinal wall thickening. Abdom Imaging 1994;9:389-394
18. Shoenut JP, Semelka RC, Margo CM, et al. Comparison of magnetic resonance imaging and endoscopy in distinguishing the type and severity of inflammatory bowel disease. J Clin Gastroenterol 1994;1:31-35
19. Semelka RC, Shoenut JP, Silverman R, Kroeker MA, Yaffe CS, Micflikier AB. Bowel disease: prospective comparison of CT and 1.5-T pre-and postcontrast MR imaging with T1-weighted fat-suppressed and breath-hold FLASH sequences. J Magn Reson Imaging 1991;1:625-632
20. Kettritz U, Isaacs K, Warshauer DM, Semelka RC. Crohn's disease: pilot study comparing MRI of the abdomen with clinical evaluation. J Clin Gastroenterol 1995;21:249-253
21. Rollandi GA, Martinoli C, Conzi R, et al. Magnetic resonance imaging of the small intestine and colon in Crohn's disease [in Italian]. Radiol Med (Torino) 1996;91:81-85
22. Hahn PF, Saini S, Cohen MS, Goldberg M, Reimer P, Mueller PR. An aqueous gastrointestinal contrast agent for use in echo-planar MR imaging. Magn Reson Med 1992;25:380-383
23. Low RN, Alzate GD, Sigeti JS, Sebrechts CP, Barone R, Lacey C. Double-contrast MR imaging of peritoneal tumors with dilute barium oral contrast, intravenous gadolinium, and breath-hold FMPSPGR imaging (abstr). Radiology 1996;201(P):252
24. Mirowitz SA. Contrast enhancement of the gastrointestinal tract on MR images using intravenous gadolinium-DTPA. Abdom Imaging 1993;18:215-219
25. Joosten FB, Jansen JB, Joosten HJ, Rosenbusch G. Staging of rectal carcinoma using MR double surface coil, MR endorectal coil, and intrarectal ultrasound: correlation with histopathologic findings. J Comput Assist Tomogr 1995;19:752-758
26. Shoenut JP, Semelka RC, Silverman R, Yaffe CS, Micflikier AB. Magnetic resonance imaging evaluation of the local extent of colorectal mass lesions. J Clin Gastroenterol 1993;17:248-253
27. Meyenberger C, Huch Boni RA, Bertschinger P, Zala GF, Klotz HP, Krestin GP. Endoscopic ultrasound and endorectal magnetic resonance imaging: a prospective, comparative study for preoperative staging and follow-up of rectal cancer. Endoscopy 1995;27:469-479
28. Semelka RC, Gesine J, Kelekis NL, Burdeny DA, Ascher SM. Small bowel neoplastic disease: demonstration by MRI. J Magn Reson imaging 1996;6:855-860
29. Hahn PF, Stark DD, Lewis JM, et al. First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging. Radiology 1990;175:695-700
30. Rubin DL, Muller HH, Sidhu MK, Young SW, Hunke WA, Gorman WG. Liquid oral magnetic particles as a gastrointestinal contrast agent for MR imaging: efficacy in vivo. J Magn Reson Imaging 1993;3:113-118
31. Winter TC, Ager JD, Nghiem HV, Hill RS, Harrison SD, Freeny PC. Upper gastrointestinal tract and abdomen: water as an orally administered agent for helical CT. Radiology 1996;201:365-370